Abstract Specific constellations of lipoprotein particle features, reflected as differences in mean lipoprotein particle diameters, are associated with risk of insulin resistance (IR) and cardiovascular disease (CVD). The associations of lipid profiles with disease risk differ by race/ethnicity, the reason for this is not clear. We aimed to examine whether there were additional genetic differences between racial/ethnic groups on lipoprotein profile. Genotypes were assessed using the Affymetrix 6.0 array in 817 related Caucasian participants of the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). Association analysis was conducted on fasting mean particle diameters using linear models, adjusted for age, sex and study center as fixed effects, and pedigree as a random effect. Replication of associations reaching P \ 1.97 9 10 -05 (the level at which we achieved at least 80 % power to replicate SNP-phenotype associations) was conducted in the Caucasian population of the Multi-Ethnic Study of Atherosclerosis (MESA; N = 2,430). Variants which replicated across both Caucasian populations were subsequently tested for association in the African-American (N = 1,594), Chinese (N = 758), and Hispanic (N = 1,422) populations Electronic supplementary material The online version of this article
of MESA. Variants in the APOB gene region were significantly associated with mean VLDL diameter in GOLDN, and in the Caucasian and Hispanic populations of MESA, while variation in the hepatic lipase (LIPC) gene was associated with mean HDL diameter in both Caucasians populations only. Our findings suggest that the genetic underpinnings of mean lipoprotein diameter differ by race/ ethnicity. As lipoprotein diameters are modifiable, this may lead new strategies to modify lipoprotein profiles during the reduction of IR that are sensitive to race/ethnicity.
Background
Different constellations of lipoprotein subfraction concentrations, reflected in the heterogeneity in lipoprotein fraction size, are now considered a biomarker of metabolic dysfunction, such as cardiovascular disease (CVD) and IR (Festa et al. 2005; Garvey et al. 2003; Goff et al. 2005; Gray et al. 1997) . Lipoprotein subfraction distribution and the associated average diameter for a fraction are modifiable through diet and exercise, making them a potential target for interventions aimed at reducing IR and CVD (Beard et al. 1996; Lemieux et al. 2002; Melenovsky et al. 2002; Wood et al. 2006) . The associations between lipoprotein size and disease risk, and the possibility that lipoprotein size may become a clinical intervention target, have increased efforts to understand the etiology of lipoprotein size heterogeneity.
Both candidate gene and genome-wide association (GWAS) approaches have been used to identify genetic risk factors for shifts in subfraction distribution (Austin et al. 1998; Couture et al. 2000; Freeman 2003; Nishina et al. 1992; Okumura et al. 2003; Osgood 2003; Rotter et al. 1996; Ruel et al. 2002; Talmud et al. 2000 Talmud et al. , 2004 Wang et al. 2002) . A recent GWAS identified 15 loci associated with the mean diameter of VLDL, LDL or HDL, but replication was reported for only 10 loci in two independent samples (Chasman et al. 2009 ). The single nucleotide polymorphism (SNP) associations with mean particle diameter were identified in Caucasian populations. Generalization beyond Caucasian populations is complicated for several reasons. First, there is evidence that dyslipidemic profiles differ between ethnic groups, with, for example, Caucasians exhibiting higher LDL-cholesterol and triglyceride levels than non-Caucasian populations (O'Meara et al. 2004) . Second, there is evidence that the relationship of dyslipidemia with CVD may differ between ethnic groups. For example, smaller LDL particle size is associated with hypertension, a risk factor for coronary heart disease, in Caucasians but not in African-Americans (Kullo et al. 2007 ). Moreover, total-and LDL-cholesterol concentrations are more strongly associated with cardiovascular disease risk in Caucasians than in African-Americans (Kral et al. 2001) . Third, the identity of individual SNPs associated with disease risk or biomarkers and their allele frequencies may differ across ethnic groups Goodarzi et al. 2003; Wung and Aouizerat 2003) .
In this study, we performed genome-wide scans in GOLDN (a Caucasian population), replicating significant findings in the Caucasian population of MESA, to identify genetic variations contributing to variation in lipoprotein diameters, as well as to confirm loci that have previously been identified. Further, we examined any replicated associations in Caucasians in non-Caucasian populations.
Methods

GOLDN study population
The original study population consisted of 1,328 men and women from 148 families consisting of a mix of familial relationships including parent-offspring (N = 614), siblings (N = 667), grandparent-grandchild (N = 89), avuncular (N = 617), half-sibling (N = 22), grand avuncular (N = 69), half avuncular (N = 23), first cousins (N = 268), half grand avuncular (N = 12), 1st cousin once removed (N = 81), half 1st cousin (N = 11), half 1st cousin once removed (N = 4) and 2nd cousin (N = 1) relationships. All participants were of European descent recruited in Minneapolis, Minnesota, and Salt Lake City, Utah. The primary aim of the GOLDN study was to characterize the role of genetic and dietary factors on an individual's response to both a high-fat meal challenge and fenofibrate intervention. The details of GOLDN have been published elsewhere (Kabagambe et al. 2009 ). Briefly, the study protocol consisted of an initial screening visit, during which participants were asked to discontinue the use of lipid-lowering drugs and over-the-counter medication that could affect lipid levels. Approximately 4-8 weeks later participants' blood samples were collected. The final sample consisted only of those willing to undergo the highfat meal protocol and a subsequent 3-week fenofibrate trial (N = 833, of which 817 individuals remained after the genotype exclusions detailed below). Although phenotype data are taken from the participants before either the highfat meal or the fenofibrate intervention, the GWAS genotyping was only conducted on those who completed the fenofibrate protocol. The protocol was approved by the Institutional Review Boards at the University of Minnesota, University of Utah, Tufts University/New England Medical Center and the University of Alabama at Birmingham. Written informed consent was obtained from all participants.
MESA study population
The MESA study population consisted of 6,814 men and women, ages 45-84 years, who identified themselves as non-Hispanic white, African-American, Hispanic, or Chinese were recruited from six regions in the United States during years [2000] [2001] [2002] . The communities included Forsyth County, North Carolina; Northern Manhattan and the Bronx, New York; Baltimore City and Baltimore County, Maryland; St Paul, Minnesota; Chicago, Illinois; and Los Angeles County, California. MESA was designed to study the prevalence, risk factors, and progression of subclinical cardiovascular disease in a multiethnic cohort. A detailed description of the study design and methods has been published previously (Bild 2002) . All participants were free of clinically apparent cardiovascular disease. All participants gave informed consent and the protocol was approved by the institutional review board of each of the study centers.
Biochemical measurements
All plasma samples used for this analysis were collected after an 8-(GOLDN) or 12-h (MESA) fast. All samples were analyzed for lipid profiles once all collections were made in each study. Measurements of VLDL, LDL, and HDL diameter were determined by nuclear magnetic resonance (NMR) spectroscopy by LipoScience (LipoScience Inc, North Carolina). NMR detects the signal emitted by lipoprotein methyl-group protons when in the field of a magnet charged at 400 MHz. The NMR signal is decoded to obtain estimates of particle numbers for each of several lipoprotein fractions. The weighted average particle diameter for each lipoprotein fraction (VLDL, LDL, and HDL) is calculated as the sum of the average lipoprotein particle diameters multiplied by the relative mass percentage, based on the amplitude of the methyl NMR signal and given in nm. NMR groups intermediate-density lipoproteins (IDL) as a subclass of LDL (Jeyarajah et al. 2006 ).
Genotyping
In both GOLDN and MESA, a total of 906,600 SNPs were genotyped using the Affymetrix Genome-Wide Human 6.0 array. Genotypes were defined using the Birdseed calling algorithm (Korn et al. 2008) .
GOLDN SNPs that were monomorphic (55,530) or had a call rate \96 % (82,462) were removed from the analysis. In addition, SNPs were excluded from the analysis based on the number of families with Mendelian errors as follows: for minor allele frequency (MAF) C20 %, removed if errors were present in [3 families (1,486 SNPs); for 20 % [ MAF C 10 %, removed if errors were present in [2 families (1,338 SNPs); for 10 % [ MAF C 5 %, removed if errors were present in [1 family (1,767 SNPs); for MAF \5 %, removed if any errors were present (9,592 SNPs). In families with remaining errors, SNPs that exhibited Mendelian error were set to missing (31,595 SNPs). Furthermore, 16 participants with call rates \96 % were also removed from any subsequent analyses. Subsequently, 748 SNPs failing the Hardy-Weinberg equilibrium (HWE) test at P value \10 -6 were excluded from association analysis.
After conducting the quality control measures above, and then excluding SNPs with MAF \1 %, those that deviate from Hardy-Weinberg Equilibrium proportions (HWE; P \ 10 -6 ), those SNPs missing strand information, and those with discrepancies with the mlinfo file, imputation was performed using MACH software (Version 1.0.16). After imputation, a hybrid dataset was created, that included 2,543,887 SNPs, of which 584,029 were initially genotyped in the GOLDN population. Missing typed data were kept as missing in the final genotype data set.
MESA sample exclusion criteria included heterozygosity [53 % and individual-level genotyping call rate \95 %. Monomorphic SNPs were removed, and there was no filter on HWE or MAF prior to release of the genotypes on dbGaP. IMPUTE version 2.1.0 was used to perform imputation for the MESA SHARe participants (chromosomes 1-22) using HapMap Phase I and II-CEU ? YRI ? CHB ? JPT as the reference panel (release #22-NCBI Build 36 (dbSNP b126)) (only the CEU reference panel was used for imputation in Caucasian participants). Relationship inference was performed using KING software (Manichaikul et al. 2010 ) to identify first-and seconddegree relatives, and an unrelated set of individuals was identified for genome-wide association analysis.
Statistical methods
Population differences
Population differences in age were examined using t tests. Population differences in gender were examined using a 2-degree of freedom (df) Chi-square (V 2 ) test of freedom. Population differences in mean lipoprotein diameter were examined using regression models with mean lipoprotein diameter as the outcome and population, age and gender as predictors.
GOLDN GWAS
Mean VLDL diameter was log-transformed to approximate a normal distribution. SNP-phenotype associations were tested using mixed linear models. The mean lipoprotein particle diameter was the outcome (for each of the lipoprotein fractions of VLDL, LDL, and HDL separately) with each SNP the predictor, and sex, age, and data collection center modeled as fixed effects, and ''pedigree'' as a random effect. The lmekin function in R software (kinship package) (Atkinson and Thereau 2007) was modeled in the association analysis to correct for the non-independence of the data points (pedigree), which uses a variance component framework to account for the genetic correlation across family members. Population substructure was assessed using principal components generated using EIGENSOFT 3.0 software. As the first 10 principal components did not show a significant association with any outcome (P [ 0.001), they were not included in the mixed models that tested for genotype-phenotype associations. The Bonferroni correction was used to establish genome-wide significance, with the chosen alpha (0.05) divided by the total number of SNPs (imputed ? genotyped; 2,543,401) giving rise to a threshold of P \ 1.97 9 10 -8
. Quantile-quantile (q-q value) plots were constructed to evaluate deviations from the expected test statistic distribution (Supplementary Figure 1) . Genome-wide Manhattan plots were generated to visualize the results (Supplementary Figure 2) .
Replication in Caucasians
The P value threshold for selecting SNPs from the Caucasian population of GOLDN for replication in the Caucasian population of MESA was chosen at P \ 1.97 9 10 -05 (see ''Nature Publishing Group '' 2012) . This threshold was validated empirically after the initial GWAS based on power analysis suggesting we would achieve 80 % power for replications.
Power analysis
At an alpha level of P \ 1.97 9 10 -05
, we report 371 significant SNP-phenotype associations ( Supplementary   Tables 1-3 ). For the power analysis only, we used a Bonferroni correction of 0.05/371 which gave rise to the alpha level of P = 0.00013 needed for 80 % power. Using a conservative MAF of 0.10, and based on an average observed effect size of b = 0.015 (Supplementary Table 4) , using an additive model, we have 84 % power to replicate our 371 findings from GOLDN and detect significant SNP-phenotype associations in the Caucasian population (N = 2,430) of MESA.
Examination of replicated SNPs in non-Caucasian populations
To reduce the likelihood of false positive findings, only associations that replicated in the Caucasian participants of MESA were subsequently examined in a third stage for associations in the non-Caucasian populations.
Examination of SNPs in the MESA populations
All mean particle diameters were log-transformed to approximate a normal distribution. To examine genetic associations, linear models were fit in R and controlled for age, sex, principal components of ancestry and data collection center. Within the full MESA cohort, we stratified by race/ethnic group and eliminated those individuals with top principal components (PCs) of ancestry[3.5 SD from the mean within any race/ethnic group. Based on our examination of principal components within each race/ethnic group, we used 3 PCs for analysis of Caucasians, 1 PC for African-Americans, 3 PCs for Hispanics, and 1 PC for Chinese. A false discovery rate (FDR) correction was used within each ethnic group and q values are reported (Benjamini and Hochberg 1995; Storey and Tibshirani 2003) .
As the sample sizes for the non-Caucasian populations are smaller than those for the Caucasian population in MESA, and MAF may differ by race/ethnicity, we conducted power analysis to examine our power to reject the null hypothesis that SNPs associating with particle diameters in Caucasians also associate with particle diameters in non-Caucasian populations (Supplemental Table 4 ). Power analysis was conducted using Quanto software v 1.2.4 (Gauderman and Morrison). The observed effects sizes (b) from the SNP-phenotype associations in the Caucasian population of MESA, as well as the observed MAF for each of the non-Caucasian populations of MESA were used to calculate our power to replicate SNP-phenotype associations. For the Hispanic population, we had over 80 % power to reject the null hypothesis for all SNP-phenotype associations. For the African-American population, we had over 80 % power reject the null hypothesis for all SNPphenotype associations, except for that of rs10184054 with mean VLDL diameter. In the Chinese population, we have over 80 % power to replicate 3 of the SNP-phenotype associations with mean VLDL diameter, but were underpowered to replicate SNP-phenotype associations with mean HDL diameter (power \0.40). Therefore, we did not try to replicate SNP associations with mean HDL diameter in the Chinese population.
The software haploview (Barrett et al. 2005 ) was used to visualize linkage disequilibrium (LD) plots for areas of the genome, for all racial/ethnic population, where there were SNPs that were significantly associated with mean lipoprotein diameters in the Caucasian populations of both GOLDN and MESA (Supplemental Figure 3) .
Results
Sample characteristics
General characteristics of the GOLDN and MESA study populations are summarized in Table 1 . No populations were significantly different in gender, but GOLDN differed from the MESA populations in age (P \ 0.0001; Table 2 ). For mean VLDL diameter, we saw ethnic differences (P \ 0.0001) between all populations except between GOLDN and the Hispanic participants of MESA (P = 0.70; Table 2 ). For mean LDL diameter the two Caucasian populations did not differ (P = 0.09), nor did the African-American population from either Caucasian population (P [ 0.05), however, the Hispanic and Chinese populations were significantly different from all other populations (P \ 0.0001; Table 2 ). With respect to mean HDL diameter, all populations were significantly different (P \ 0.001; Table 2 ). Initial GWAS, conducted on the GOLDN population, gave rise to genomic control parameters lambda of k = 1.0 for mean VLDL diameter, k = 1.1 for mean LDL diameter, and k = 1.2 for mean HDL diameter ( Supplementary  Figure 1) . Given our sample size, k \ 1.1 may be expected. Phenotype distribution did not deviates significantly from normal, and pedigree structure was checked using genotypes (allele sharing) as part of GOLDN protocol; therefore, we could exclude these potential sources of inflation as the cause of the elevated genomic control lambda for mean HDL particle size.
For mean VLDL diameter, 6 SNP associations reached genome-wide levels of significance in the ApoB gene region on Chromosome 2 (P \ 1.97 9 10 -8 ; Table 3 ; Supplementary Figure 2) . Potential regions of interest, with a number of SNP associations above the threshold for replication were additionally seen in the budding uninhibited by benzimidazoles 3 homolog (BUB3) gene on chromosome 10 and an intergenic region on chromosome 12 (Supplementary Table 1 ; Supplementary Figure 2) . LDL showed no SNP associations at genome wide levels of significance (Supplementary Table 2 ), but the Manhattan plots showed areas of borderline association in the collagen, type XXVII, alpha 1 (COL27A1) gene, and RNA (guanine-7-) methyltransferase (RNMT) genes. The only genome-wide significant association with mean HDL diameter was an SNP (rs427614) near the potassium voltage-gated channel, KQT-like subfamily, member 4 (KCNQ4) gene (P = 3.08 9 10 -9 ), and 5 SNPs in the Scinderin (SCIN) gene on chromosome 7.
An alpha of P \ 1.97 9 10 -5 was chosen as the criterion for replication in MESA. At this alpha level 89 SNPs were associated with mean VLDL diameter, of which 60 SNPs occur across 14 known loci and 29 are intergenic; 88 SNPs were associated with mean LDL diameter, of which 43 were across 22 known loci, and 45 SNPs were in intergenic regions; and 195 SNPs were associated with mean HDL diameter which represented 114 SNPs across 44 known loci, and 81 intergenic SNPs (Supplemental Tables 1-3) .
Replication
Of the SNPs meeting the criterion for replication in MESA, 4 replicated SNP associations were seen with mean VLDL Table 3 SNPs reaching alpha levels of significance of P \ 1.97 9 10 diameter, and 3 SNP associations were replicated with mean HDL diameter, in the Caucasian population of MESA with estimated FDR q value \0.05; for all significant SNP-phenotype findings, the direction of effect was the same across populations (Table 3 ). In the Caucasian MESA sample, we replicated associations for four variants in the APOB gene with mean VLDL diameter (all P = 0.001; q value = 0.01), and three in the hepatic lipase (LIPC) gene with mean HDL diameter (all P \ 1.97 9 10 -5 ; q value = 0.007). There were no replicated SNPphenotype associations with mean LDL diameter across the two samples in Caucasians. The LD structure for the APOB gene region, for each racial/ethnic population is displayed in Supplementary Figure 3 . LIPC variants were not in LD so are not visualized.
The significant SNP-phenotype associations on the APOB and LIPC genes were examined for associations with mean VLDL and HDL particle diameters, respectively, in the Hispanic and African-American populations; and the significant SNP-phenotype associations on the APOB gene was examined for associations with mean VLDL particle diameter in the Chinese population (Table 3) . SNPs in APOB gene region were significantly associated with mean VLDL diameter in Hispanics (all P \ 0.001; q value = 0.01), but not in African-Americans or Chinese populations (all P [ 0.05). SNPs in LIPC did not show associations with mean HDL diameter in any non-Caucasian populations (all P [ 0.05; Table 3 ).
Discussion
To our knowledge, this is the first study to use genomewide data to explicitly examine whether genetic variants associating with lipoprotein diameter in Caucasians also associate with those same lipoprotein diameters in nonCaucasian populations. We provide evidence that there is heterogeneity across the racial groups; the variants in the APOB gene region that were associated with mean VLDL diameter in Caucasian and Hispanic populations, did not show the same associations in African-American and Chinese populations. In addition, variation across the intronic region of the LIPC gene was suggestively associated with mean HDL diameters but only in Caucasians.
In our data, we report four SNPs to be associated with mean VLDL diameter (rs10184054, rs6544366, rs6728178, and rs7557067). These SNPs were not shown to be significant in previous analysis, but 2 SNPs in LD with rs10184054, rs6544366, rs6728178, and rs7557067 have been previously associated with total VLDL concentration, small VLDL concentration and mean VLDL diameter (rs676210) and mean LDL diameter, triglycerides and medium VLDL concentration previously (rs673548; Chasman et al. 2009 ). This is strong evidence to support the association of SNPs in the APOB gene with mean VLDL diameter in Caucasians. We report that SNPs in APOB were associated with mean VLDL diameter in the Hispanic but not African-American or Chinese populations of MESA. MAFs are somewhat lower in these latter two populations; while this suggests that the genetic associations of VLDL diameter may differ across ethnic groups, the genetic background of each race/ethnicity must be considered when interpreting the results.
Our analysis suggested that variants in the LIPC locus are associated with mean HDL diameter in Caucasians. The LIPC locus was associated with HDL size in the GWAS reported by Chasman et al. (2009) , but in the same paper, this association did not replicate. In our study, variants at this locus did not reach genome-wide levels of significance in GOLDN but met our criterion for discovery and replication, thus providing further, but not conclusive, evidence that variants on the LIPC may affect HDL particle diameter in Caucasians.
It is not entirely clear why we found race and ethnicityspecific SNP associations. While the LD structure of genotyped SNPs in the ApoB gene region was somewhat different for African-Americans compared with Caucasians and Hispanics, this was not the case for Chinese. Given that lipoprotein diameters are influenced by many genes, future research should examine the entire genome for associations with lipoprotein diameters in non-Caucasian populations. In addition, future research could examine racial and ethnic differences in other lipidemia phenotypes, such as ApoB to ApoE ratio. Non-genetic differences between the populations and gene-environment interactions should also be considered; given research showing that association between HDL-C and polymorphisms on the LIPC gene may be modified by dietary intake (Nettleton et al. 2007 ).
Our study must be considered in the light of several limitations. Replication of SNPs significantly associated with mean particle diameter in GOLDN, but not in the Caucasian population of MESA, remains an immediate concern. Differences between the two samples must be considered as a possible source of lack of replication; for example 13-18 % of MESA participants (dependent on race/ethnicity) were on lipid-lowering drugs at the time of data collection, whereas there was a washout period for such in GOLDN. Only mean HDL diameter was significantly different between those Caucasian participants of MESA taking, and those Caucasian participants not taking, lipid-lowering drugs (a finding replicated in GOLDN; Frazier- Wood et al. 2012 ). Although we cannot fully exclude the role that lipid-lowering drugs may have played in mediating the relationship between genetic variation and mean lipoprotein diameter, we highlight that a similar percentage of participants across all populations of MESA were taking a lipid-lowering drug, lending support to our ethnicity-specific findings. Nonetheless, the results should be interpreted with caution and we are further unable to exclude ethnicity-specific responses to the medications. In addition, although our SNP-phenotype associations are replications of previous findings in Caucasians, giving us confidence in their validity, it is not clear why we failed to replicate several loci that were associated with mean particle diameter in a previous GWAS (Chasman et al. 2009 ). This may arise from the relatively modest sample size in the initial GWAS, or from baseline differences used in the initial discovery GWAS, such as the mixed-gender population in GOLDN, compared to the female only sample of Chasman et al. (2009) GWAS.
Nonetheless, we provide strong evidence that SNPs in or near APOB are associated with VLDL size in Caucasian and Hispanic populations, but perhaps not in African-American or Chinese populations; and variation in the LIPC gene is associated with mean HDL diameter in Caucasian populations, but not in Hispanic or African-American populations. The implication is that the differences seen in lipoprotein subclass profiles stratified by race/ethnicity may be at least partially genetically determined. As lipoprotein diameters are modifiable through diet, exercise and pharmacological interventions (Beard et al. 1996; Lemieux et al. 2002; Melenovsky et al. 2002; Wood et al. 2006) , how the analysis presented here should inform race-and ethnicity-stratified prediction and treatment of IR warrants further research efforts.
